Mike Sathekge is a Professor and Head of Nuclear Medicine department at University of Pretoria and Steve Biko Academic Hospital. He heads the South African Nuclear Medicine Research Infrastructure. Prof Sathekge has published over 230 peer-reviewed articles, excluding abstracts and book chapters. He is one of the global leaders concerning treatment of prostate cancer using targeted alpha therapy. He also led and introduced several targeted molecular imaging and therapeutic probes in infection and oncology in Africa. Mike is the Editor-in-Chief of Seminars in Nuclear Medicine and an Associate Editor of the European Journal of Nuclear Medicine and Molecular Imaging and the Journal of Nuclear Medicine and the World Journal of Nuclear Medicine. Prof Sathekge is the President of the World Association of Radiopharmaceuticals and Molecular Therapy and the chair of the ASSAf panel on research, development, and innovation of peaceful uses of nuclear technologies in South Africa. Mike holds numerous scientific honours and awards.